x

Search for a clinical trial

* (*) mandatory field

A Phase II Study of the Efficacy and Safety of Lenalidomide Combined to Escalating Doses of Chemotherapy in Intermediate-2-or High Risk Myelodysplastic Syndrome (MDS) and Acute Myeloid Leukemia (AML) With Del 5q

  • Type of clinical trial : Drug clinical trial
  • Recruiting project : Yes
  • Status : Ongoing trial
  • Funding body(ies) :
  • Geographic coverage : National
  • Sponsor : Groupe francophone des myélodysplasies (gfm)
  • Website
  • Principal investigator of clinical trial

  • Dr Lionel ADES
  • Groupe Francophone des Myélodysplasies (GFM)
  • Service d'Hématologie Séniors
  • CHU Paris-GH St-Louis Lariboisière F.Widal - Hôpital Saint-Louis
  • 1 avenue Claude Vellefaux
  • 75010 PARIS
  • FRANCE
  • More information
  • Phone  : 33 (0)1 71 20 70 59
  • Fax  : -
  • Website
  • Contact secretary  :
Last update: November 2014

Additional information

The documents contained in this web site are presented for information purposes only. The material is in no way intended to replace professional medical care by a qualified specialist and should not be used as a basis for diagnosis or treatment.